Medtecs International (TPE:9103) 5-Year RORE % : 0.09% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:9103 Medtecs International Corp Ltd TPE:9103
70 GF Score
Price NT$5.12
GF Value NT$7.67
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Medtecs International 5-Year RORE %?

Medtecs International TPE:9103 -1.92% 70 5-Year RORE % is 0.09 as of Dec. 2025. GuruFocus rates TPE:9103 with a GF Score™ of 70/100 and a GF Value™ of NT$7.67 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 702 Medical Devices & Instruments companies, Medtecs International ranks better than 57.26% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Medtecs International's 5-Year RORE % for the quarter that ended in Dec. 2025 was 0.09%.

The industry rank for Medtecs International's 5-Year RORE % or its related term are showing as below:

TPE:9103's 5-Year RORE % is ranked better than
57.26% of 702 companies
in the Medical Devices & Instruments industry
Industry Median: -5.185 vs TPE:9103: 0.09

Medtecs International  (TPE:9103) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Medtecs International 5-Year RORE % Related Terms


Medtecs International 5-Year RORE % Historical Data

* Premium members only.

The historical data trend for Medtecs International's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtecs International 5-Year RORE % Chart

Medtecs International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.82 -35.38 -37.19 100.76 0.09

Medtecs International Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -37.19 -103.64 100.76 100.50 0.09

TPE:9103 vs ISRG, BDX, MDLN: 5-Year RORE % Comparison

For the Medical Instruments & Supplies subindustry, Medtecs International's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtecs International 5-Year RORE % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtecs International's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Medtecs International's 5-Year RORE % falls into.


TPE:9103
70GF Score
Medtecs International Corp Ltd TPE:9103
5-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medtecs International 5-Year RORE % Calculation

Medtecs International's 5-Year RORE % for the quarter that ended in Dec. 2025 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( -0.274-0.881 )/( -1342.63-1.353 )
=-1.155/-1343.983
=0.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 5-year before.

Frequently Asked Questions Learn more about 5-Year RORE % →
What does a 5-Year RORE % of 0.09 mean?
Medtecs International (TPE:9103) has a 5-Year RORE % of 0.09 as of Dec. 2025. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Medtecs International and its competitors. According to the industry distribution chart, Medtecs International ranks #300 out of 702 companies in the Medical Devices & Instruments industry, placing it in the top 42.7%.
Is Medtecs International's 5-Year RORE % too high?
Medtecs International's current 5-Year RORE % is 0.09. Based on the distribution chart, Medtecs International ranks #300 out of 702 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medtecs International has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medtecs International's 5-Year RORE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medtecs International ranks #300 out of 702 companies for 5-Year RORE %. This puts Medtecs International in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year RORE % for a Medical Devices & Instruments company?
A good 5-Year RORE % depends on the Medical Devices & Instruments industry context. However, 5-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year RORE % mean?
A high 5-Year RORE % can signal that a stock is expensive relative to its fundamentals. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Medtecs International and its competitors. Medtecs International's current 5-Year RORE % is 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtecs International stock overvalued right now?
Based on GuruFocus' analysis, Medtecs International (TPE:9103) is currently considered Possible Value Trap. The stock's GF Value™ is NT$7.67, compared to a current price of NT$5.12 — trading 33.2% below its estimated fair value. The current 5-Year RORE % is 0.09. Medtecs International's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year RORE % calculated?
5-Year RORE % is calculated from a company's financial statements. For Medtecs International (TPE:9103), the current 5-Year RORE % is 0.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medtecs International (TPE:9103) Overvalued in 2026?

Based on GuruFocus' analysis, Medtecs International stock appears to be undervalued. The current stock price of NT$5.12 is trading 33.2% below its estimated GF Value™ of NT$7.67. GuruFocus considers Medtecs International to be Possible Value Trap.

Key valuation signals for TPE:9103:

  • 5-Year RORE %: 0.09
  • GF Value™: NT$7.67 vs. price of NT$5.12 (33.2% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the TPE:9103 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medtecs International Business Description

Other Exchanges 546:Singapore
Address SongGao Road, 11th Floor, No. 9, Xinyi District, Taipei, TWN, 110
Medtecs International Corp Ltd is an investment holding company. The company, along with its subsidiaries, is a manufacturer of medical consumables and provides healthcare products and services. It operates in three segments. The Manufacturing segment produces and sub-contracts medical consumables, including patients' apparel, disposable surgical masks, boot covers and surgical gowns, adult diapers, underpads, crochet blankets, bed linens and medical bandages. The Hospital services segment provides laundry and leasing services. The Distribution segment is involved in the marketing of Medtecs-branded medical consumables to hospitals, pharmacies, and other end users in Asia Pacific and through online channels. It generates the majority of its revenue from the Manufacturing segment.
70GF Score

Get the complete analysis for TPE:9103

5-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$5.12
Price
NT$7.67
GF Value